Narcolepsy
- PMID: 1630637
Narcolepsy
Abstract
Narcolepsy is a chronic neurologic disorder characterized by excessive daytime sleepiness, cataplexy, and premature onset of rapid eye movement sleep. It can be differentiated from other disorders causing daytime drowsiness by its clinical symptoms and by sleep laboratory studies. The disorder usually begins in adolescence and remains present throughout life. Genetic susceptibility to narcolepsy is closely associated with specific HLAs that indicate the existence of a gene in the region of the major histocompatibility complex on chromosome 6 that increases susceptibility to narcolepsy. Neurochemical studies of human and canine narcolepsy have demonstrated disturbed monoaminergic and cholinergic function that may account for impaired regulation of rapid eye movement sleep, but the link between these abnormalities and the genetic factors is still unknown. Treatment of sleepiness with stimulants and cataplexy with tricyclic antidepressants leads to substantial improvement but does not fully resolve symptoms in most patients.
Similar articles
-
[Narcolepsy].Rev Neurol (Paris). 1985;141(8-9):515-27. Rev Neurol (Paris). 1985. PMID: 2868518 Review. French.
-
[Wake disorders. I. Primary wake disorders].Rev Neurol (Paris). 1998 Feb;154(2):111-29. Rev Neurol (Paris). 1998. PMID: 9773032 Review. French.
-
The neurobiology of narcolepsy-cataplexy syndrome.Int J Neurol. 1991-1992;25-26:29-40. Int J Neurol. 1991. PMID: 11980061 Review.
-
[Advances in the diagnosis and treatment of narcolepsy-cataplexy syndrome].Rev Neurol. 2008 May 1-15;46(9):550-6. Rev Neurol. 2008. PMID: 18446698 Review. Spanish.
-
Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.Sleep Med Rev. 2005 Aug;9(4):269-310. doi: 10.1016/j.smrv.2005.03.004. Sleep Med Rev. 2005. PMID: 16006155 Review.
Cited by
-
Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers.Psychopharmacology (Berl). 1993;113(1):76-82. doi: 10.1007/BF02244337. Psychopharmacology (Berl). 1993. PMID: 7862832
-
Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy.J Physiol. 2005 Nov 1;568(Pt 3):1003-20. doi: 10.1113/jphysiol.2005.085829. Epub 2005 Aug 25. J Physiol. 2005. PMID: 16123113 Free PMC article.
-
CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1667-73. doi: 10.1136/jnnp.74.12.1667. J Neurol Neurosurg Psychiatry. 2003. PMID: 14638887 Free PMC article.
-
Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy.J Neurosci. 1997 Aug 15;17(16):6401-8. doi: 10.1523/JNEUROSCI.17-16-06401.1997. J Neurosci. 1997. PMID: 9236248 Free PMC article.
-
Narcolepsy in children: a practical guide to its diagnosis, treatment and follow-up.Paediatr Drugs. 2000 Jan-Feb;2(1):1-9. doi: 10.2165/00148581-200002010-00001. Paediatr Drugs. 2000. PMID: 10937454 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources